| Molecular docking analysis of phyto-constituents from Cannabis sativa with pfDHFR TI David, NS Adelakun, OI Omotuyi, DS Metibemu, OE Ekun, OK Inyang, ... Bioinformation 14 (9), 574, 2018 | 47 | 2018 |
| Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS‐CoV‐2 drug targets: in vitro validation of furin inhibition IO Omotuyi, O Nash, BO Ajiboye, VO Olumekun, BE Oyinloye, ... Phytotherapy Research 35 (2), 908-919, 2021 | 39 | 2021 |
| Flavones scaffold of Chromolaena odorata as a potential xanthine oxidase inhibitor: Induced Fit Docking and ADME studies B Kikiowo, AJ Ogunleye, OK Inyang, NS Adelakun, OI Omotuyi, ... BioImpacts: BI 10 (4), 227, 2020 | 26 | 2020 |
| Molecular docking and 3D qsar studies of C000000956 as a potent inhibitor of bace-1 OA Joseph, K Babatomiwa, A Niyi, O Olaposi, I Olumide Drug research 69 (08), 451-457, 2019 | 19 | 2019 |
| Chromolaena odorata flavonoids attenuate experimental nephropathy: Involvement of pro-inflammatory genes downregulation OI Omotuyi, O Nash, OA Enejoh, EI Oribamise, NS Adelakun Toxicology Reports 7, 1421-1427, 2020 | 16 | 2020 |
| Discovery of new promising USP14 inhibitors: computational evaluation of the thumb-palm pocket N Adelakun, I Obaseki, A Adeniyi, O Fapohunda, E Obaseki, O Omotuyi Journal of Biomolecular Structure and Dynamics 40 (7), 3060-3070, 2022 | 14 | 2022 |
| Polypharmacology of some medicinal plant metabolites against SARS-CoV-2 and host targets: Molecular dynamics evaluation of NSP9 RNA binding protein S Bandyopadhyay, OA Abiodun, BC Ogboo, AT Kola-Mustapha, EI Attah, ... Journal of Biomolecular Structure and Dynamics 40 (22), 11467-11483, 2022 | 12 | 2022 |
| Induced fit docking and automated QSAR studies reveal the ER-α inhibitory activity of cannabis sativa in breast cancer B Kikiowo, AJ Ogunleye, O Iwaloye, TT Ijatuyi, NS Adelakun, WO Alashe Recent Patents on Anti-Cancer Drug Discovery 16 (2), 273-284, 2021 | 12 | 2021 |
| Virtual screening and pharmacokinetic studies of potential MAO-B inhibitors from traditional Chinese medicine B Kikiowo, JA Ogunleye, DS Metibemu, IO Omotuyi, NS Adelakun Journal of Biological Engineering Research and Review 7 (1), 08-15, 2020 | 12 | 2020 |
| Darunavir disrupts critical nodes in metastable 2019-nCoV-RBD/ACE-2 complex OI Omotuyi, O Nash, BO Ajiboye, DS Metibemu, BE Oyinloye, ... Preprints, 2020 | 10 | 2020 |
| T‐705‐modified ssRNA in complex with Lassa virus nucleoprotein exhibits nucleotide splaying and increased water influx into the RNA‐binding pocket OI Omotuyi, O Nash, D Safronetz, AA Ojo, TH Ogunwa, NS Adelakun Chemical Biology & Drug Design 93 (4), 544-555, 2019 | 9 | 2019 |
| Agemone mexicana flavanones; apposite inverse agonists of the β2-adrenergic receptor in asthma treatment GO Eniafe, DS Metibemu, OI Omotuyi, AJ Ogunleye, OK Inyang, ... Bioinformation 14 (2), 60, 2018 | 9 | 2018 |
| Automated QSAR and docking study of phyto-ligands of chromolaena odorata as inhibitor of bacteria beta-lactamase enzyme TI David, DC Okonkwo, NS Adelakun, OI Omotuyi Journal of Biological Engineering Research and Review 6 (2), 32-42, 2019 | 3 | 2019 |
| Identification of Gly/NMDA receptor Antagonist from Chromolaena odorata’s Derived compounds using Induced Fit Docking and ADME study TI David, OI Omotuyi, OD Agboola, DC Okonkwo, NS Adelakun J. Biol. Eng. Res. Rev 6, 19-26, 2019 | 3 | 2019 |
| Identification of Gly/NMDAR Antagonist from Chromolaena odorata’s Derived Phytoconstituents using Induced Fit Docking Approach TI David, OI Omotuyi, OD Agboola, DC Okonkwo, NS Adelakun bioRxiv, 610006, 2019 | 1 | 2019 |
| Analyzing protein posttranslational modifications using enzyme-catalyzed expressed protein ligation N Adelakun, J Parrish, N Chu Methods in Enzymology 682, 319-350, 2023 | | 2023 |
| Phytoconstituents from Markhamia tomentosa bind to HPV oncoprotein with apoptogenic potential: a molecular modeling approach. MB Ibrahim, AT Kola-Mustapha, NS Adelakun, NA Koorbanally | | 2021 |
| Molecular binding signatures of Trigonella foenum-graecum compounds on cyclin-dependent kinase 4 for possible anti-cancer mechanism in breast cancer OA Enejoh, H Rasheed-Jada, GO Eniafe, AJ Ogunleye, EI Oribamise, ... GSC Biological and Pharmaceutical Sciences 11 (3), 041-021, 2020 | | 2020 |
| Takeda G-protein Receptor (TGR)-5 Evolves Classical Active-state Conformational Signatures in Complex with Chromolaena Odorata-derived Flavonoid-5, 7-dihydroxy-6-4 … OI Olaposi, N Oyekanmi, MD Samuel, OA Enejoh, UO Victor, A Niyi Current Chemical Biology 13 (3), 212-222, 2019 | | 2019 |
| Inhibition of Insulin Receptor Tyrosine Kinase by the Firmicutes Metabolome during Insulin Resistance AAOIO Adewale J Ogunleye, Ojochenemi A Enejoh, Gabriel O Eniafe, Olumide K ... Archives of Endocrinology and Diabetes Care 2 (1), 154 - 163, 2018 | | 2018 |
omotuyi idowuAfe Babalola University, Ado EkitiVerified email at abuad.edu.ng
